Replenishing a patient's blood cells after chemotherapy, radiation

Cedars-Sinai Health Sciences University researchers have discovered that a protein called R-spondin 2 can expedite the recovery of the bone marrow's blood stem cell niche after chemotherapy and radiation treatment. This finding, published in the journal Blood, could potentially lead to new treatments that help cancer patients recover more quickly after these therapies.

The niche is a specialized environment that supports blood-forming stem cells, and its recovery is crucial for the body to resume producing necessary blood cells. The study's senior author, Dr. John Chute, likened the niche to the soil in a garden where blood stem cells thrive. He explained that chemotherapy and radiation damage the niche cells, preventing the blood stem cells from regenerating and leading to a depletion of the patient's blood count.

The researchers found that R-spondin 2, when administered to mice exposed to total body irradiation, accelerated the recovery of the niche. This discovery could pave the way for future research focused on enhancing niche repair mechanisms, ultimately improving patient recovery after chemotherapy and radiation.

Brief written by urgent.news from Medical Xpress's own syndicated text. Machine-written — may contain errors; check the original before relying on it.